Double blind controlled randomized study on azathioprine efficacy in multiple sclerosis. Preliminary results
- PMID: 3281916
- DOI: 10.1007/BF02334408
Double blind controlled randomized study on azathioprine efficacy in multiple sclerosis. Preliminary results
Abstract
The preliminary results of a double blind controlled prospective randomized trial of Azathioprine for therapeutic efficacy in 38 patients with Multiple Sclerosis are reported. Progression of the disease is significantly reduced in Azathioprine-treated group in comparison to Placebo-treated patients, but this effect is reached only after 3 years of treatment (P less than 0.025) regardless of the clinical course and without affecting relapse rate.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical